Key statistics
As of last trade Repare Therapeutics Inc (RPTX:NSQ) traded at 2.89, 6.64% above its 52-week low of 2.71, set on Sep 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.97 |
---|---|
High | 3.09 |
Low | 2.85 |
Bid | 2.86 |
Offer | 2.89 |
Previous close | 2.97 |
Average volume | 164.98k |
---|---|
Shares outstanding | 42.51m |
Free float | 42.09m |
P/E (TTM) | -- |
Market cap | 126.26m USD |
EPS (TTM) | -2.00 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 18:21 GMT.
More ▼
Press releases
- Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib
- Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results
- Repare Therapeutics Announces Updated Positive Safety and Tolerability Results from the Phase 1 MYTHIC Clinical Trial
- Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-3467, a Polθ ATPase Inhibitor
- Repare Therapeutics Announces Phase 1 Data Highlighting Camonsertib in Combination with Radiotherapy Treatment Presented at the ASTRO Annual Meeting
- Repare Therapeutics Announces New Data Underscoring Need for Additional Treatment Solutions for Patients with Metastatic Gynecologic Cancers
- Repare Therapeutics to Present Data from Phase 1/2 TRESR Clinical Trial Evaluating Camonsertib Monotherapy in Multiple Advanced Solid Tumors Harboring ATM Loss-of-Function at ESMO Congress 2024
- Repare Therapeutics Announces Strategic Reprioritization to Focus on Broad Clinical Portfolio
- Repare Therapeutics to Participate in Two Upcoming Investor Conferences
More ▼